Apoorva Mehta: Medicines to become major consumer products as demand accelerates

Apoorva Mehta: Medicines to become major consumer products as demand accelerates
Apoorva Mehta: Medicines set for growth

The market for medicines is poised for substantial growth, supported by robust consumer demand. Apoorva Mehta cited the significant revenue generated by the molecule tirzepatide, used in medications like Mounjaro and Zepbound, which already surpasses Netflix in earnings. According to Mehta, this suggests that pharmaceuticals are set to play a larger role in the consumer sector over the coming 20 years. He points out that the growing acceptance and use of innovative therapies could transform the landscape of consumer products, with medicines leading that charge.

Mehta recently appeared on a Progress podcast to discuss capital allocation strategies and AI trends. He has also discussed how breakthroughs in AI reasoning could drive adoption of advanced models across industries. These comments reflect his ongoing focus on innovation in both healthcare and technology.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.